Skip to search.
 TSX Up 0.24% TSX Ventures Up 0.49%

More On NRI.TO

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Nuvo Pharmaceuticals Inc. (NRI.TO)

-Toronto
7.00 Down 0.05(0.71%) Jul 22, 3:56PM EDT
Prev Close:7.05
Open:7.00
Bid:7.00
Ask:7.07
1y Target Est:N/A
Beta:-0.393214
Earnings Date:Aug 3 - Aug 8 (Est.)
Day's Range:6.95 - 7.03
52wk Range:3.32 - 7.30
Volume:27,446
Avg Vol (3m):17,924
Market Cap:80.41M
P/E (ttm):N/A
EPS (ttm):-0.75
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in CAD.

Headlines

Key Statistics

Forward P/E (1 yr):9.72
P/S (ttm):3.26
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :0.60
Quarterly EPS Est (Jun-16) :0.20
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Nuvo Research Inc. operates as a life sciences company. The company operates through two segments, Nuvo Pharma and Crescita. It offers Pennsaid, a topical non-steroidal anti-inflammatory drug that is used to treat the signs and symptoms of osteoar... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback